Global Predictive Diagnostics Market Research Report 2023

Publication ID:

PB503232538

Publication Date:

March 9, 2023

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

Predictive diagnostics听is a field of听medicine听that entails predicting the听probability听of听disease听and instituting preventive measures in order to either prevent the disease altogether or significantly decrease its impact upon the patient.
Highlights
The global Predictive Diagnostics market was valued at US$ 1584.4 million in 2022 and is anticipated to reach US$ 2607.9 million by 2029, witnessing a CAGR of 8.7% during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
North American market for Predictive Diagnostics is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for Predictive Diagnostics is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The global market for Predictive Diagnostics in Hospital is estimated to increase from $ million in 2023 to $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global companies of Predictive Diagnostics include Qiagen, Myriad Genetics, Roche, Genomic Health, LabCorp, Epistem, BioGenex and Abbott, etc. In 2022, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Predictive Diagnostics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Predictive Diagnostics.
The Predictive Diagnostics market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Predictive Diagnostics market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Predictive Diagnostics companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.
By Company
Qiagen
Myriad Genetics
Roche
Genomic Health
LabCorp
Epistem
BioGenex
Abbott
Segment by Type
Genetic Testing
Carrier Identification
Cancer Testing
Others
Segment by Application
Hospital
Clinic
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Predictive Diagnostics companies鈥� competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Predictive Diagnostics Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Genetic Testing
1.2.3 Carrier Identification
1.2.4 Cancer Testing
1.2.5 Others
1.3 Market by Application
1.3.1 Global Predictive Diagnostics Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Predictive Diagnostics Market Perspective (2018-2029)
2.2 Predictive Diagnostics Growth Trends by Region
2.2.1 Global Predictive Diagnostics Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Predictive Diagnostics Historic Market Size by Region (2018-2023)
2.2.3 Predictive Diagnostics Forecasted Market Size by Region (2024-2029)
2.3 Predictive Diagnostics Market Dynamics
2.3.1 Predictive Diagnostics Industry Trends
2.3.2 Predictive Diagnostics Market Drivers
2.3.3 Predictive Diagnostics Market Challenges
2.3.4 Predictive Diagnostics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Predictive Diagnostics Players by Revenue
3.1.1 Global Top Predictive Diagnostics Players by Revenue (2018-2023)
3.1.2 Global Predictive Diagnostics Revenue Market Share by Players (2018-2023)
3.2 Global Predictive Diagnostics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Predictive Diagnostics Revenue
3.4 Global Predictive Diagnostics Market Concentration Ratio
3.4.1 Global Predictive Diagnostics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Predictive Diagnostics Revenue in 2022
3.5 Predictive Diagnostics Key Players Head office and Area Served
3.6 Key Players Predictive Diagnostics Product Solution and Service
3.7 Date of Enter into Predictive Diagnostics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Predictive Diagnostics Breakdown Data by Type
4.1 Global Predictive Diagnostics Historic Market Size by Type (2018-2023)
4.2 Global Predictive Diagnostics Forecasted Market Size by Type (2024-2029)
5 Predictive Diagnostics Breakdown Data by Application
5.1 Global Predictive Diagnostics Historic Market Size by Application (2018-2023)
5.2 Global Predictive Diagnostics Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Predictive Diagnostics Market Size (2018-2029)
6.2 North America Predictive Diagnostics Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Predictive Diagnostics Market Size by Country (2018-2023)
6.4 North America Predictive Diagnostics Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Predictive Diagnostics Market Size (2018-2029)
7.2 Europe Predictive Diagnostics Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Predictive Diagnostics Market Size by Country (2018-2023)
7.4 Europe Predictive Diagnostics Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Predictive Diagnostics Market Size (2018-2029)
8.2 Asia-Pacific Predictive Diagnostics Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Predictive Diagnostics Market Size by Region (2018-2023)
8.4 Asia-Pacific Predictive Diagnostics Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Predictive Diagnostics Market Size (2018-2029)
9.2 Latin America Predictive Diagnostics Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Predictive Diagnostics Market Size by Country (2018-2023)
9.4 Latin America Predictive Diagnostics Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Predictive Diagnostics Market Size (2018-2029)
10.2 Middle East & Africa Predictive Diagnostics Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Predictive Diagnostics Market Size by Country (2018-2023)
10.4 Middle East & Africa Predictive Diagnostics Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Qiagen
11.1.1 Qiagen Company Detail
11.1.2 Qiagen Business Overview
11.1.3 Qiagen Predictive Diagnostics Introduction
11.1.4 Qiagen Revenue in Predictive Diagnostics Business (2018-2023)
11.1.5 Qiagen Recent Development
11.2 Myriad Genetics
11.2.1 Myriad Genetics Company Detail
11.2.2 Myriad Genetics Business Overview
11.2.3 Myriad Genetics Predictive Diagnostics Introduction
11.2.4 Myriad Genetics Revenue in Predictive Diagnostics Business (2018-2023)
11.2.5 Myriad Genetics Recent Development
11.3 Roche
11.3.1 Roche Company Detail
11.3.2 Roche Business Overview
11.3.3 Roche Predictive Diagnostics Introduction
11.3.4 Roche Revenue in Predictive Diagnostics Business (2018-2023)
11.3.5 Roche Recent Development
11.4 Genomic Health
11.4.1 Genomic Health Company Detail
11.4.2 Genomic Health Business Overview
11.4.3 Genomic Health Predictive Diagnostics Introduction
11.4.4 Genomic Health Revenue in Predictive Diagnostics Business (2018-2023)
11.4.5 Genomic Health Recent Development
11.5 LabCorp
11.5.1 LabCorp Company Detail
11.5.2 LabCorp Business Overview
11.5.3 LabCorp Predictive Diagnostics Introduction
11.5.4 LabCorp Revenue in Predictive Diagnostics Business (2018-2023)
11.5.5 LabCorp Recent Development
11.6 Epistem
11.6.1 Epistem Company Detail
11.6.2 Epistem Business Overview
11.6.3 Epistem Predictive Diagnostics Introduction
11.6.4 Epistem Revenue in Predictive Diagnostics Business (2018-2023)
11.6.5 Epistem Recent Development
11.7 BioGenex
11.7.1 BioGenex Company Detail
11.7.2 BioGenex Business Overview
11.7.3 BioGenex Predictive Diagnostics Introduction
11.7.4 BioGenex Revenue in Predictive Diagnostics Business (2018-2023)
11.7.5 BioGenex Recent Development
11.8 Abbott
11.8.1 Abbott Company Detail
11.8.2 Abbott Business Overview
11.8.3 Abbott Predictive Diagnostics Introduction
11.8.4 Abbott Revenue in Predictive Diagnostics Business (2018-2023)
11.8.5 Abbott Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

Companies Mentioned:

Qiagen
Myriad Genetics
Roche
Genomic Health
LabCorp
Epistem
BioGenex
Abbott

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂